| Literature DB >> 35171017 |
Aaron Reuben1, Erika M Manczak2, Laura Y Cabrera3, Margarita Alegria4,5, Meghan L Bucher6, Emily C Freeman7, Gary W Miller6, Gina M Solomon8,9, Melissa J Perry10.
Abstract
BACKGROUND: To date, health-effects research on environmental stressors has rarely focused on behavioral and mental health outcomes. That lack of research is beginning to change. Science and policy experts in the environmental and behavioral health sciences are coming together to explore converging evidence on the relationship-harmful or beneficial-between environmental factors and mental health.Entities:
Mesh:
Year: 2022 PMID: 35171017 PMCID: PMC8848757 DOI: 10.1289/EHP9889
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Examples of human features and animal model correlates for mental health conditions: behavioral features and correlates.
| Human behavioral features | Behavioral correlates in animal models | |
|---|---|---|
| Attention deficit/hyperactivity disorder | Hyperactivity | Increased activity in the open field test |
| Inattention | Slow reaction times and inaccuracy during operant tasks | |
| Impulsivity | Perseverance in accessing stimulus despite aversive consequence | |
| Substance use disorder | Substance seeking regardless of conflict or punishment | Animals preferentially choosing to use substances over eating or drinking |
| Pathological choice of drug over other necessities (e.g., food, water) | Animals tolerating aversive stimulus (e.g., foot shock or pharmacological agents such as histamine) to access drug | |
| Persistence of drug-associated behavior(s) during extinction paradigm | ||
| Major depressive disorder | Apathy | Impaired nest-building, disturbed grooming regimen |
| Anhedonia | Reduced preference for palatable solutions or food (e.g., sucrose water or cookies) | |
| Despair | Decreased escape attempts in forced swim test | |
| Irritability | Increased aggression when intruder animal is introduced to resident animal’s cage | |
| Obsessive compulsive disorder | Uncontrollable repetitive thoughts | NA |
| Uncontrollable repetitive behaviors | Excessive grooming | |
| Schedule induced polydipsia | ||
| Post-traumatic stress disorder | Recurring, involuntary, and intrusive memories | NA |
| Derealization or dissociation | NA | |
| Hypervigilance | Increased startle response |
Note: NA, Not Applicable.
Examples of human features and animal model correlates for mental health conditions: Neuroimaging and neurochemical correlates.
| Human neuroimaging features | Neurochemical correlates in animal models | ||
|---|---|---|---|
| ADHD | fMRI | Reduced blood flow in fronto-striatal, fronto-cerebellar, and fronto-striato-parieto-cerebellar networks | Dysregulated dopamine metabolism and transmission |
| Increased blood flow in posterior parietal lobe, PCC, and regions of dlPFC | |||
| PET | Abnormal dopamine transporter binding, dopamine receptor binding, and dopamine metabolism in right caudate | Dysregulated (increased or decreased) extracellular dopamine and/or norepinephrine concentrations | |
| Decreased | |||
| Decreased dopamine transporter density in midbrain | Decreased spontaneously active ventral tegmental area dopaminergic neurons | ||
| DTI | Abnormal white matter structural anatomical connectivity in fronto-striatal circuitry, fronto-cerebellar circuitry, and executive functioning and attentional networks | Impaired modulation of cortico-striato-thalamo-cortical circuits | |
| SUD | fMRI | Hypoactive PFC during cognitive tasks | Increased dopamine signaling |
| rsMRI | Decreased connectivity in the default mode network | Increased activity in mesolimbic pathway | |
| PET | Reduced regional brain glucose metabolism in PFC and ACC | ||
| EEG | Altered P300 on reward processing tasks | Dysregulated hypothalamic-pituitary-adrenal activity | |
| MDD | fMRI | Increased activity in mPFC, amygdala, and hippocampus | Increased circulating glucocorticoids and decreased glucocorticoid receptors |
| Decreased activity in IPFC, and striatum | |||
| PET | Hyperactivity in the mPFC | Increased pro-inflammatory cytokines and decreased anti-inflammatory cytokines | |
| Altered metabolism and neural activity in the PCC, insula, hippocampus, and amygdala | |||
| Altered serotonin receptor binding | Decreased serotonin levels | ||
| DTI | Abnormal white matter integrity in superior longitudinal fasciculus, corpus callosum, and uncinate fasciculus | Decreased hippocampal brain derived neurotrophic factor expression | |
| MRI/VBM | Decreased volume in mPFC, IPFC, striatum, amygdala, and hippocampus | ||
| OCD | rsMRI | Abnormal functional connectivity in OFC and ACC | Altered cortico-basal ganglia-thalamo-cortical activity |
| PET/SPECT | Intrusive thought-induced hyperactivity in the OFC | Altered dopamine receptor subtype composition and dopamine receptor binding | |
| Anxiety related hyperactivity in the ACC | Disturbed redox balance | ||
| OCD stimuli-induced increased activity in OFC and ACC | Altered firing and postsynaptic currents in bed nucleus of the stria terminalis neurons | ||
| MRI/CT/VBM | Structural changes in OFC, ACC, basal ganglia, and thalamus | Altered cyclic adenosine-monophosphate phosphodiesterase signaling | |
| Altered serotonin reuptake transporter expression | |||
| PTSD | fMRI | Hyperactivity in the amygdala | Increased stress hormones |
| Hypoactivity in the mPFC and ACC | Increased epigenetic methylation of brain-derived neurotrophic factor gene in hippocampus | ||
| Reduced hippocampal activity | Upregulated corticotropin releasing factor receptors in stria terminalis | ||
| MRI/MRS | Structural changes in hippocampus, amygdala, and mPFC | Decreased hippocampal plasticity | |
| Increased cortical and hippocampal expression of glucocorticoid receptors | |||
Note: ADHD findings summarized in Weyandt et al. (2013) and Russell (2005, 2007). SUD findings summarized in Cabrera et al. (2016) and Koob and Simon (2009). MDD findings summarized in Wise et al. (2014), Krishnan and Nestler (2011), and Wang et al. (2017). OCD findings summarized in Holzschneider and Mulert (2011) and Szechtman et al. (2017). PTSD findings summarized in Holzschneider and Mulert (2011) and Borghans and Homberg (2015). Endogenous event-related potentials between 300–600 ms after cue (P300). ACC, anterior cingulate cortex; ADHD, attention deficit/hyperactivity disorder; CT, computerized tomography; d, dorsal; DTI, diffusion tensor imaging; EEG, electroencephalogram; fMRI, functional MRI; IPFC, inferior prefrontal cortex; l, lateral; m, medial; MDD, major depressive disorder; mPFC, medial prefrontal cortex; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; OCD, obsessive compulsive disorder; OFC, orbitofrontal cortex; PET, positron emission tomography; PFC, prefrontal cortex; PCC, posterior cingulate cortex; PTSD, posttraumatic stress disorder; rsMRI, resting state MRI; SPECT, single photon emission computerized tomography; SUD, substance use disorder; VBM, voxel based morphometry.
Figure 1.Conceptual model of the association of environmental hazards with mental health outcomes at the individual and community level.
Major classes of neurotoxicants and their typical exposure sources and neurotoxic action.
| Class of toxicant | Typical exposure sources | Typical neurotoxic action | Animal model examples |
|---|---|---|---|
| Metals | Metals are naturally occurring, but human exposure is usually due to current or historical uses. Current sources include mining, smelting, battery manufacturing and recycling, construction, automotive, and electronics. | Toxicity and action vary by metal and dose (e.g., lead is toxic at all levels, whereas copper is essential at low levels and harmful at high). Metals generally harm the CNS by substituting for necessary minerals (e.g., lead substitutes for calcium, which is critical to neuronal signaling), binding to and inactivating necessary enzymes (e.g., arsenic can inactivate | Prenatal and neonatal lead exposure in mice results in learning deficits and hyperactivity that is attenuated by amphetamine or methylphenidate ( |
| Organic solvents | Solvents are used as vehicle and equipment fuels; in almost all chemical and industrial processes; and as ingredients in cleaning and degreasing products, pesticides, paints, adhesives, cosmetics, coatings, and ink. | Toxicity and action vary by solvent and dose, but typically organic solvents are lipophilic and concentrate in lipid-rich brain white matter. Mechanisms of toxicity remain poorly characterized but are related to generation of toxic reactive oxygen species. Consequences can involve dysregulation of glial cells, demyelination of nerve fibers, ischemic damage, and white matter necrosis. | Adult mice acutely exposed to toluene show depressive symptoms as measured by increased time spent immobile during the tail suspension test and forced swim test, which is indicative of despair. These symptoms are not the result of an overall decrease in movement and are reversed via treatment with antidepressants ( |
| Pesticides | Pesticides are applied in agriculture and manufacturing processes, in parks, golf courses, rights of way, and home and garden use. | Toxicity and action vary by pesticide, but the best-studied classes, organophosphates and carbamate pesticides, inhibit acetylcholinesterase resulting in accumulation of acetylcholine and disrupted neurotransmission in the parasympathetic nervous system. | Young mice (1 month of age) exposed subchronically or chronically to glyphosate demonstrate both depressive and anxiety behaviors including decreased time spent in open arms of an elevated plus maze ( |
Note: CNS, central nervous system.